The University of Tennessee Graduate School of Medicine, Knoxville



The Department of Medicine

Mahmoud Shorman, MD

Associate Professor
Chief, Division of Infectious Diseases
Division of Infectious Diseases

Research Focus

Dr. Shorman is interested in multiple issues related to skin, bone and heart infections, both in terms of best approaches using antibiotics and hospital processes that lead to best outcomes.

Education

Medical School
Jordan University of Science and Technology, Irbid, Jordan, 1996

Residency
Internal Medicine Residency Training Program, New York Medical College/Metropolitan Hospital Center, New York, NY, 2000

Rotation in transplant infectious diseases at Vanderbilt University, Nashville, TN, 2001

Fellowship

Infectious Diseases Fellowship Training Program, East Tennessee State University, Johnson City, TN, 2002


Certifications

American Board of Internal Medicine, 2000 - present
American Board of Internal Medicine - Infectious Diseases 2002 - present
Infection Control, 2007- present

Professional Affiliations

Fellow of the Infectious Diseases Society of America
Society for Healthcare Epidemiology of America

Current Publications

Yeager SD, Oliver JE, Shorman MA, Wright LR, Veve MP.
Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections. International Journal of Antimicrobial Agents. 2021 Mar 27:106329. [Epub ahead of print]

Morelli MK, Veve MP, Lorson W, Shorman MA.
Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor. Mycoses. 2021 Feb;64(2):181-186. Epub 2020 Nov 21.

Dhabaan G, Chahin A, Buhaish A, Shorman M.
COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know? Journal of Infection in Developing Countries. 2020 Dec 31;14(12):1374-1379.

Veve MP, Patel N, Smith ZA, Yeager SD, Wright LR, Shorman MA.
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. International Journal of Antimicrobial Agents. 2020 Oct 23:106210. Available in PubMed: Nov 2020. [Epub ahead of print]

Hennessy K, Shorman M.
Verrucous plaques on the face, dysphagia, and limb weakness. Cleveland Clinic Journal of Medicine. 2020 Oct 1;87(10):587-589.

Cooksey GE, Epps JL, Moye RA, Patel N, Shorman MA, Veve MP.
Impact of a plan of care protocol on patient outcomes in people who inject drugs with infective endocarditis. The Journal of Infectious Diseases. 2020 Sep 2;222(Supplement_5):S506-S512.

Morelli MK, Veve MP, Shorman MA.
Maternal bacteremia caused by staphylococcus aureus with a focus on infective endocarditis. Open Forum Infectious Diseases. 2020 Jun 19;7(8):ofaa239. eCollection 2020 Aug. Available in PubMed: Aug 2020.

Majdick K, Kaye K, Shorman MA.
Central nervous system blastomycosis clinical characteristics and outcomes. Medical Mycology. 2020 May 29. [Epub ahead of print]

Veve MP, McCurry ED, Cooksey GE, Shorman MA.
Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States. PLoS One. 2020 Mar 10;15(3):e0230199. eCollection 2020.

Lorson W, Veve MP, Heidel E, Shorman MA.
Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States. BMC Infectious Diseases. 2020 Jan 8;20(1):24.

Humphrey C, Veve MP, Walker B, Shorman MA.
Long-term vancomycin use had low risk of ototoxicity. PLoS One. 2019 Nov 6;14(11):e0224561. eCollection 2019.

Walker B, Heidel E, Shorman M.
Clinical characteristics and outcome of staphylococcus aureus prostate abscess, ten-year experience at a tertiary care center. Open Forum Infectious Diseases. 2019 Aug 20. [Epub ahead of print]

Lorson WC, Heidel RE, Shorman MA.
Microbial epidemiology of infectious endocarditis in the intravenous drug abuse population: A retrospective study. Infectious Diseases and Therapy. 2019 Jan 23. [Epub ahead of print]

Jackson LE, Shorman M.
A case of bilateral nocardia francinia adrenal abscesses in an intravenous drug-using splenectomized patient with tricuspid endocarditis. Open Forum Infectious Diseases. 2018 Jul 1;5(7):ofy141. eCollection 2018 Jul.

Aljindan RY, Hussein NE, Khoudair HA, Shaikh AY, Hassan HA, Alabdulqader NA, Shorman MA, Abdalhamid BA.
First description of plasmid mediated quinolone resistance genes in salmonella isolates from Saudi hospitals. Saudi Medical Journal. 2018 Jul;39(7):685-689.

Shorman M, Evans D, Gibson C, Perfect J.
Cases of disseminated cryptococcosis in intravenous drug abusers without HIV infection: A new risk factor? Medical Mycology Case Reports. 2016 Dec 2;14:17-19. eCollection 2016 Dec.

Current Presentations

Majdick K, Kaye K, Shorman M. CNS blastomycosis: A descriptive analysis and review of diagnosis and treatment. Presented at IDWeek; 2019 Oct 2-6; Washington, DC.

Morelli MK, Lorson W, Shorman M. There was a fungus among us: A cohort of fungal infectious endocarditis cases in East Tennessee. Presented at IDWeek; 2019 Oct 2-6; Washington, DC.

Livesay JE, Lorson WC, Heidel ER, Shorman M. Do I really need a transesophageal echo? Comparing echocardiographic modalities in native valve infective endocarditis due to methicillin-resistant staphylococcus aureus. Presented at IDWeek; 2019 Oct 2-6; Washington, DC.

Lorson W, Das A, Heidel R, Shorman M. Microbial epidemiology of infectious endocarditis in the intravenous drug abuse population: A retrospective study in East Tennessee. Presented at IDWeek; 2018 Oct 3-7; San Francisco, CA.

Lorson W, Das A, Heidel R, Shorman M. Factors that increase the likelihood of inpatient mortality in the endocarditis patient; A retrospective study. Presented at American College of Physicians Tennessee Chapter Annual Scientific Meeting; 2018 Oct 26-27; Chattanooga, TN.

Top



Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2019